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Background: The CXC chemokine receptor 4 (CXCR4) and its li-
gand, stromal cell–derived factor-1 (SDF-1a or CXC chemokine li-
gand 12) are involved in the trafficking of leukocytes into and out
of extravascular tissues. The purpose of this study was to determine
whether SDF-1a secreted by host cells plays a role in recruiting in-
flammatory cells into the periodontia during local inflammation.
Methods: SDF-1a levels were determined by enzyme-linked im-
munosorbent assay in gingival crevicular fluid (GCF) of 24 individ-
uals with periodontitis versus healthy individuals in tissue biopsies
and in a preclinical rat model of Porphyromonas gingivalis lipopoly-
saccharide–induced experimental bone loss. Neutrophil chemotaxis
assays were also used to evaluate whether SDF-1a plays a role in the
recruitment of host cells at periodontal lesions.
Results: Subjects with periodontal disease had higher levels of
SDF-1a in their GCF compared to healthy subjects. Subjects with
periodontal disease who underwent mechanical therapy demon-
strated decreased levels of SDF-1a. Immunohistologic staining
showed that SDF-1a and CXCR4 levels were elevated in samples
obtained from periodontally compromised individuals. Similar re-
sults were observed in the rodent model. Neutrophil migration was
enhanced in the presence of SDF-1a, mimicking immune cell migra-
tion in periodontal lesions.
Conclusions: SDF-1a may be involved in the immune defense
pathway activated during periodontal disease. Upon the develop-
ment of diseased tissues, SDF-1a levels increase and may recruit
host defensive cells into sites of inflammation. These studies suggest
that SDF-1a may be a useful biomarker for the identification of peri-
odontal disease progression. J Periodontol 2008;79:845-853.
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P
eriodontal diseases are among
the most prevalent infections
in humans; they are charac-
terized by the classic hallmarks of
the inflammatory response, includ-
ing erythema and edema.1 Late
sequelae of periodontal diseases
include the loss of alveolar bone,
periodontal ligament attachment,
and, ultimately, teeth. Therefore,
earlier detection and treatment
would lead to improved outcomes
for patients.2
Gingival crevicular fluid (GCF) is
a serum ultrafiltrate of blood origi-
nating from the vasculature subja-
cent to the sulcus. GCF flow rates
and the increased concentration of
molecules that mediate innate and
adaptive immune responses corre-
late with the severity of periodontal
inflammation. As such, numerous
GCF constituents have been char-
acterized to identify biomarkers
that may be used to monitor the in-
itiation and progression of gingival
inflammation and the immune re-
sponse.
Chemokines are a group of small
molecular weight proteins char-
acterized by their ability to induce
directional movement of a variety
of cell types. Stromal derived fac-
tor-1 (SDF-1a and b or CXC
chemokine ligand 12 [CXCL12])
is a potent chemoattractant that
belongs to the C-X-C chemokine
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family, which was originally isolated from a murine
bone marrow stromal cell line.3 At least two SDF-1
species have been described that are derived by alter-
native splicing of the SDF-1/CXCL12 gene and share
similar biologic activities. SDF-1a is widely expressed
in many tissues during development, including the ep-
ithelium surrounding the developing tooth bud.4
SDF-1a is a powerful chemoattractant for hematopoi-
etic cells, including neutrophils; it was demonstrated
to facilitate their transmigration across endothelial
cell barriers.5 However, vascular endothelial cells in
other tissues, such as those lining pulmonary chan-
nels, may not secrete SDF-1a.6 This suggests that
SDF-1a is selectively expressed by endothelial cells
in certain tissues, perhaps in response to specific
signals or tissue damage. This may provide a mech-
anism to localize hematopoietic cells to specific tissue
compartments.7-9
Based on the involvement of SDF-1a in hemopoi-
etic cell homing, we hypothesized that the epithelial
lining of the gingival sulcus or endothelial cells may
secrete the chemokine to recruit mononuclear cells
to inflammatory sites. In in vitro studies, we noted that
SDF-1a recruited neutrophils, and in preclinical ani-
mal models, SDF-1a was expressed in the gingival
and sulcular epithelium. GCF samples were collected
from clinically healthy subjects and from subjects with
chronic periodontal disease. Based on the protein
levels, GCF from patients with periodontal disease
have significantly higher levels of SDF-1a than sub-
jects without periodontal disease. There was also a
decrease in SDF-1a levels collected from sites after
successful treatment with local mechanical therapy
measures (scaling and root planing). These data sug-
gest that SDF-1a may represent a chemoattractant
for host defense cells and may serve as a biomarker
in GCF for periodontal diseases.
MATERIALS AND METHODS
Immunohistochemistry for SDF-1a and CXCR4
Archival gingival tissue specimens (N = 12) were ob-
tained from the Division of Oral Pathology, Depart-
ment of Periodontics and Oral Medicine, University
of Michigan, under a protocol approved by the Univer-
sity of Michigan’s Institutional Review Board (IRB).
Specimens were obtained from individuals with peri-
odontal disease or from controls with non-inflamed
gingiva and no periodontal attachment loss. The sam-
ples were fixed in 10% neutral buffered formalin,
embedded in paraffin, and 2- to 3-mm slides were pre-
pared. The slides were deparaffinized and dehydrated
with xylene, ethanol (100%, 95%, and 70%), and dis-
tilled water. The samples were treated with anti-
human SDF-1a (immunoglobulin G [IgG]1; clone
79018.111‡‡) for 1 hour at room temperature or an
anti-human CXCR4 antibody diluted 1:100 (10 mg/
ml), IgG2a (clone 44708.111),§§ or controls (IgG1
or IG2aii) and with a cell and tissue staining kit for
mouse primary IgG antibodies¶¶ and 1:20 antibody
concentration.
Neutrophil Isolation
Normal peripheral blood isolates## containing a mix-
ture of monocytes, lymphocytes, platelets, plasma,
and red blood cells were derived from healthy volun-
teers who were reported to be non-smoking and who
had not taken any prescribed medications prior to
donation. Neutrophils were recovered from the whole
blood anticoagulant citrate dextrose solution (3%
citric acid and 6% sodium citrate*** using 4% dex-
trose†††) and inverted. Half volumes of dextran (6%)
and 0.9% NaCl were added, and the mixture was
placed at room temperature for 1 hour to separate.
The supernatant was centrifuged at 1,150 revolutions
per minute (rpm) for 12 minutes at 4C and then re-
suspended in ice-cold double-distilled H2O and 0.6
M KCl. It was centrifuged at 1,300 rpm for 6 minutes
at 4C and resuspended in phosphate buffered saline
(PBS), overlaid on ficol-hypaque,‡‡‡ and centrifuged
at 1,500 rpm for 30 minutes at 4C.
SDF-1a Chemotaxis Assay
Recovered neutrophils in Roswell Park Memorial Insti-
tute (RPMI) 1640 with 0.5% bovine serum albumin
(BSA) were loaded in the top chamber (5 · 105
cells/well) of a plate with 5.0-mm pores.§§§ Recombi-
nant human SDF-1a (200 ng/ml)iii was added to
650 ml RPMI 1640 with 0.5% BSA in the lower cham-
ber. Cells were incubated for 5 hours at 37C. Cells
that migrated completely to the bottom chamber were
counted manually using a hemocytometer.
Porphyromonas gingivalis Lipopolysaccharide
(LPS)-Induced Periodontal Bone Loss Model
The protocol for the induction of alveolar bone loss
was adapted from a method previously reported
using Porphyromonas gingivalis LPS–mediated bone
loss.10,11 The procedures used for LPS isolation from
P. gingivalis W83 were described by Darveau and
Hancock.12 Adult male Sprague-Dawley rats (weigh-
ing ;250 g each [N = 12]) had experimental peri-
odontitis induced by the intragingival delivery of
P. gingivalis W83 endotoxin (10 ml of a 1.0-mg/ml
preparation). Injection sites included the gingival in-
terproximal regions between the maxillary first, second,
‡‡ R&D Systems, Minneapolis, MN.
§§ R&D Systems.
ii Sigma, St. Louis, MO.
¶¶ Cell and Tissue Staining Kit for Mouse Primary IgG Antibodies,
R&D Systems.
## Normal Peripheral Blood Leukopaks, Cambrex, East Rutherford, NJ.
*** Sigma.
††† Mallinckrodt Baker, Phillipsburg, NJ.
‡‡‡ Histopaque-1077, Sigma.
§§§ Costar Transwell, Corning, Lowell, MA.
iii R&D Systems.
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and third molars and the mesial aspect of the maxil-
lary first molar. The administrations were repeated
three times per week over an 8-week period using cus-
tom-designed 0.375-inch, 33-gauge, 30 bevel nee-
dles attached to a 50-ml syringe.¶¶¶ Control animals
were treated with PBS vehicle via the same delivery
routine. At sacrifice, block biopsies of the maxillae
were harvested and immediately fixed in 10% formalin
at 4C, decalcified in 10% EDTA (pH 7.4) for 10 days,
and embedded in paraffin.
Study Populations
Power calculations were performed to estimate the re-
quired sample size.### A minimum of 11 subjects per
group was required for a 95% chance of detecting a
statistically significant difference between the healthy
and diseased groups at an alpha set at 0.05 and the
power of the study set at 80%. Twenty-four subjects
from the Comprehensive Care Clinics at University
of Michigan School of Dentistry, who consented to
participate in a study approved by the University of
Michigan IRB Health, were evaluated between June
2003 and December 2005. Inclusion criteria for dis-
eased subjects included the presence of ‡15 teeth
and a diagnosis of generalized chronic periodontitis.
Subject inclusion criteria for periodontitis were the
presence of at least four periodontal sites with probing
depth (PD) ‡4 mm, evidence of clinical attachment
loss (CAL), and bleeding on probing (BOP). Inclusion
criteria for healthy individuals included PD <4 mm, no
evidence of attachment loss, and <10% of sites with
BOP. Exclusion criteria for healthy subjects included
diabetes, immunocompromised subjects, presence
of orthodontic devices, periodontal treatment 12
months prior to the initiation of the study, or individ-
uals who had taken antibiotics within 6 months prior
to the clinical examination. The medical and dental
histories of the subjects were obtained by a standard-
ized health questionnaire. PD and CAL were measured
at six sites per tooth (mesio-buccal, buccal, disto-
buccal, mesio-lingual, lingual, and disto-lingual) us-
ing a periodontal probe. When possible, four of the
deepest sites in each quadrant were selected for sam-
pling in each subject. The selected sites corresponded
to the deepest PDs associated with ‡1 mm of CAL and
the presence of BOP. No specific instructions pertain-
ing to oral hygiene or diet prior to sample collection
were provided to the subject.
To determine whether SDF-1a is involved in target-
ing inflammatory cells to human periodontal lesions,
the presence of SDF-1a in the GCF of healthy and dis-
eased individuals was explored. The clinical parame-
ters of the participants are presented in Table 1. Ten
healthy subjects and 14 subjects who were diagnosed
as ‘‘diseased’’ met the inclusion criteria for the study.
The group consisted of seven males and 17 females
ranging between 18 and 89 years of age (mean,
46.57 – 19.60 years) (Table 1). Twenty-four sites were
sampled from healthy subjects, whereas 45 sites were
sampled from those with disease. The mean PD at
healthy sites was 2.2 – 0.6 mm compared to 5.2 – 1.4
mm at diseased sites with 1.4 – 0.6 mm loss of clinical
attachment. Ten percent of the healthy sites sampled
displayed BOP compared to 93% of the diseased sites
(Table 1). In some cases, diseased subjects required
initial periodontal therapy consisting of oral hygiene in-
struction and scaling and root planing. These therapies
ranged from two to four sessions of 60 to 90 minutes




SDF-1a levels in GCF were determined from samples
collected from gingival sulci or diseased periodontal
Table 1.
Characteristics of Subjects According to
Age, Gender, Smoking History, and
Periodontal Status
Healthy Periodontal Disease







Mean 44.7 – 16.6 46.1 – 24.2
Range 22 to 65 18 to 89
Males (n) 30.0% (3) 28.6% (4)
Sites examined (n) 24 45
Attachment loss (mm)
Mean 0.0 – 0.0 2.1 – 0.9*
Range 0.0 to 0.0 1.0 to 4.0
PD (mm)
Mean 2.2 – 0.6 5.2 – 1.4*
Range 1.0 to 3.0 4.0 to 8.0
BOP (n subjects) 10% (1) 93% (13)
Smoking history
(mean [pack-years])
Current 3 (23) 0
Past 0 3 (25)
None 7 11
* P <0.05.
¶¶¶ Hamilton, Reno, NV.
### DSS Research, Fort Worth, TX.
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pockets from the healthy and diseased patients. The
samples from healthy subjects were collected from
the mesio-buccal surface of the first molars (if pres-
ent) or the most posterior tooth in the quadrant (if
the first molar was absent). Diseased sites were se-
lected as the most severe sites in each quadrant. Each
sample was collected from the site after drying and
removing supragingival plaque. A gingival fluid col-
lection strip**** was placed in the selected sulcus
or periodontal pocket for 30 seconds for GCF collec-
tion. Individual samples were placed in 1 ml PBS con-
taining protease inhibitors (protease inhibitor cocktail;
4-[2-aminoethyl] benzesulfonyl fluoride hydrochlo-
ride, aprotinin, bestatin, EDTA, E-64, leupeptin, and
pepstatin A††††) and stored at -80C until assayed.
Each sample was analyzed by double antibody sand-
wich ELISA using recombinant human SDF-1a‡‡‡‡ as
a standard. To normalize the resulting SDF-1a levels in
the GCF, total protein was determined against a BSA
standard.§§§§
Statistical Analysis
Each investigation was repeated at least three times.
A non-parametric Mann-Whitney test was used to de-
tect any treatment differences. When significant, a
Wilcoxon rank-sum test was used to test for pairwise
differences, using Tukey’s multiple comparison ad-
justment. A 5% significance level was set for all tests.
RESULTS
SDF-1a Is Expressed in Human Tissues Derived
From Inflamed Gingiva
Chronic periodontitis or non-inflamed gingival tissue
specimens exhibited staining for SDF-1a by the sulc-
ular and gingival epithelial cells (Figs. 1A through
1D). The SDF-1a staining was significantly more in-
tense in the periodontitis tissues, throughout the
thickness of the epithelium (Figs. 1C and 1D). The un-
derlying connective tissue also showed evidence of
SDF-1a expression in the periodontitis tissues. Vascu-
lar endothelial cells were positive in all of the periodon-
titis tissues (Figs. 1E and 1F). Infiltrating leukocytes
were more prominent in areas of localized SDF-1a ex-
pression in all of the periodontitis sections and ex-
pressed abundant CXCR4 (Figs. 1I through 1K). The
few leukocytes seen in the non-inflamed tissues did
not stain for SDF-1a (not shown). None of the speci-
mens incubated with non-immune IgG (a control for
specificity) demonstrated staining (Figs. 1G and 1H).
Human Neutrophils Respond to SDF-1a
Through Chemotaxis
Next, we investigated whether human neutrophils
respond chemotactically to SDF-1a. In vitro chemo-
taxis assays were performed using peripheral blood
obtained from clinically healthy volunteers. As antic-
ipated, 65% – 3.2% of the assayed neutrophils mi-
grated toward SDF-1a compared to 28% – 1.4% of
the cells in the negative control (PBS) (Fig. 2).
SDF-1a Is Expressed in an Experimental
Periodontitis Animal Model
An animal model of experimental periodontitis was
used for the induction of alveolar bone loss using P.
gingivalis LPS. Animals were sacrificed 8 weeks fol-
lowing disease induction. The experimental protocol
of LPS delivery led to localized tissue inflammation
and corresponding (;50% to 80%) alveolar bone de-
struction (Fig. 3B). In the vehicle-treated animals,
minimal to no bone loss and inflammation was noted
(Fig. 3A). Weak SDF-1a staining was present
throughout the soft tissues of the LPS-injected ani-
mals, which was not present in the vehicle-treated
animals (not presented), whereas intense staining
was observed in the interproximal and retromolar
regions. High-powered microscopic examination of
the retromolar areas (Figs. 3C and 3D) and interprox-
imal areas (Figs. 3E and 3F) revealed significant
SDF-1a staining associated with the P. gingivalis
LPS administration.
SDF-1a Levels in Human GCF
Preliminary investigations were performed to ensure
that the GCF sampling methods were compatible with
detecting SDF-1a. SDF-1a was detected by an ELISA
assay using known concentrations of recombinant
human SDF-1a absorbed onto and eluted from the
gingival fluid collection strips (data not shown). Fol-
lowing these studies, the levels of SDF-1a in the
GCF of healthy subjects and those with periodontal
disease were evaluated and normalized against total
protein in the sample. The average level ofSDF-1a de-
tected in samples from healthy sites was 27.2 – 6.8
ng/mg total protein (Fig. 4). Because degradation of
SDF-1a plays a significant role in regulating the
bioavailability of the chemokine, a second sample,
harvested in an identical manner, was collected from
these sites. The average concentration of SDF-
1a identified in the second sample was 13.9% greater
(29.3 – 10.4 ng/mg); however there was not a signif-
icant difference between the two samples (data not
presented).
GCF levels of SDF-1a identified in samples col-
lected from diseased sites were significantly higher
(65.3 – 4.91 ng/mg total protein) than the levels de-
tected in healthy sites (27.22 – 6.39 ng/mg) (Fig.
4A). A select group of subjects initially classified as
having attachment loss underwent periodontal therapy
**** Periopaper, Oraflow, Plainview, NY.
†††† Sigma.
‡‡‡‡ R&D Systems.
§§§§ RC DC Protein Assay Kit, BioRad Laboratories, Hercules, CA.
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consisting of oral hygiene instruction and scaling and
root planing. Samples collected from these patients
4 to 8 weeks (mean, 6 – 1.5 weeks) following initial
therapy demonstrated a 68% mean decrease in
SDF-1a levels from 65.7 – 5.0 ng/mg total protein
to 21.0 – 7.6 ng/mg total protein. As before, a second
sample of GCF from this set of individuals revealed
that the initial sample contained less SDF-1a, possibly
Figure 1.
SDF-1a and CXCR4 expression in normal and periodontal diseased human gingiva. Human gingival specimens were stained for the expression
of SDF-1a immunohistochemistry (red) and counterstained by hematoxylin (blue). Samples were derived from normal non-inflamed gingival tissues
removed for crown-lengthening procedures (A, B, and E) or were obtained from subjects diagnosed with moderate chronic periodontal disease (C, D,
and F). G and H) Antibody (IgG1) specificity for the SDF-1 antibodies used by staining moderate chronic periodontal disease tissues. I through L)
The samples were derived from subjects diagnosed with moderate chronic periodontal disease and stained for CXCR4 (I, J, K) or an IgG2 control for
specificity (L). The sections demonstrate significant cellular infiltrates into the diseased connective tissues and staining for SDF-1a in the epithelia
(C and D) and endothelial cells (F). CXCR4 staining in the connective tissues (I and J) and CXCR4 associated with an inflammatory infiltrate
(K; arrows). (Original magnification: A, C, and G, ·10; B, D, and H, ·40; E and F and I through L, ·100.)
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representing protein degradation. Stratifying the sam-
ples by PD, those derived from sites with PDs £5 mm
had significantly lower SDF-1a levels (32.77 – 21.1
ng/mg) compared to sites with PDs >5 mm (76.4 –
49.3 ng/mg) (Fig. 4B). The levels of SDF-1a detected
from healthy and diseased sites in males tended to be
higher than in females; however, these differences
were not significant (data not shown). There were
no differences noted between the SDF-1a levels in dis-
eased smoking subjects relative to diseased non-
smoking subjects (data not shown).
DISCUSSION
These studies demonstrated that SDF-1a levels
change in response to periodontal inflammation. In
sites with no or minimal CAL (£5 mm) demonstrated
SDF-1a levels at 27.2 – 6.8 ng/mg total protein. GCF
samples derived from sites with the greatest CAL
(e.g., subjects with periodontitis) demonstrated sig-
nificantly higher levels of SDF-1a (65.7 – 4.91 ng/
mg total protein). This level of SDF-1a represents
roughly one-third to one-half of that required to in-
duce neutrophil chemotaxis. This suggests that indi-
vidual periodontal sites, the epithelial lining of the
periodontal sulcus or pocket, may release higher con-
centrations of SDF-1a to attract more neutrophils to
amplify the immune response corresponding to the
aggressiveness of the disease. Be-
cause it is unlikely that SDF-1a se-
rum levels change in response to
local infections, our findings agree
with the histologic observations
that SDF-1a provides a biologic
explanation for cellular trafficking
into the local periodontal infection
sites.
Classic immunopathological
studies on the progressive ‘‘natural
history’’ of periodontal diseases re-
ported that the earliest detectable
lesion (or ‘‘initial lesion’’) that can
be observed after oral hygiene
treatment usually occurs within 2
to 4 days and begins as a classic
vasculitis.13 Initially, neutrophils
or polymorphonuclear leukocytes
(PMNs) migrate through the coro-
nal aspects of the junctional epithe-
lium and may play a destructive
role in the loss of contact between
the tooth and the junctional epi-
thelium, thereby initiating the for-
mation of pocket epithelium.14
Once located against the sulcular
epithelium and possibly entering
into the gingival crevice, neutro-
phils are known to degranulate while in the process
of ingesting plaque bacteria. Complement and other
acute-phase proteins derived from the vasculature
are believed to play an important role in the initiation
of host defenses against local periodontal infec-
tions.15 These and other proteins may participate in
periodontal pathogenesis by recruiting acute and
chronic inflammatory cells attempting to neutralize
pathogens and their toxins.
Figure 2.
SDF-1a acts as a neutrophil chemoattractant. Peripheral blood
neutrophils (5 · 105) were placed in a plate with a pore size of
5.0 mm with or without the presence of SDF-1a. Neutrophils
demonstrated higher migration toward SDF-1a compared to a
negative control (PBS). *Significance at P <0.05. E = exponent.
Figure 3.
SDF-1a expression in P. gingivalis LPS–induced periodontal bone loss. Rats were injected with
vehicle (A, C, and E) or P. gingivalis LPS (B, D, and F) for 8 weeks to induce disease. Interproximal
(E and F) and retromolar (C and D) regions of the experimental groups. (Horseradish peroxidase
3-amino-9-carbazole stain; original magnification: A and B, ·2; C through F, ·20.)
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Macrophages and lymphocytes are key cells in-
volved in the host response and the early destruction
of periodontal tissues. It is well known that neutrophils
arekeycells involved in thehost responseandearlyde-
struction of periodontal tissues.16-18 In addition, previ-
ous studies19-23 showed leukocytes to be responsive to
SDF-1a. Therefore, based on the observation that the
epithelium expresses SDF-1a, a chemoattractant for
neutrophils, which are abundant in the gingival crev-
icular area during gingival inflammation, we reasoned
that SDF-1a may regulate the transepithelial migration
of neutrophils into the gingival lesions.
The mechanism that regulates the expression of
SDF-1a in the gingiva is poorly understood. Under
most conditions, SDF-1a is expressed under basal
conditions that may be modified by inflammatory me-
diators, such as cytokines. The cytokines interleukin
(IL)-1, tumor necrosis factor-alpha (TNF-a), vascular
endothelial growth factor (VEGF), and transforming
growth factor (TGF)-b1 have been the most widely
examined when the response seems to be largely de-
pendent on the cell type studied. For example, using
primary dermal and gingival fibroblasts, Fedyk et al.24
observed that monocyte-derived IL-1 and TNF-a
decreased SDF-1a secretion. Likewise, TNF-a, inter-
feron-gamma (IFN-g), and TGF-b1 enhanced SDF-
1 expression by human gingival fibroblasts, whereas
heat killed P. gingivalis, and P. gingivalis LPS reduced
SDF-1a production.25 Other inflammatory cytokines,
including IFN-g and IL-6 and -8, were not able to reg-
ulate the production of SDF-1a by human dermal fi-
broblasts.24 For thyroid fibroblasts and thymocytes,
both of which express basal levels of SDF-1a mRNA,
IL-1 and TNF do not seem to alter SDF-1a secretion
significantly.26 Likewise, SDF-1a production by bone
marrow–derived endothelium is enhanced or de-
creased by IL-1 or TNF, respectively.27 VEGF and
basic fibroblast growth factor (bFGF) were reported
to increase SDF-1a expression in endothelial cells28
and in several prostate cancer cell lines.16 Con-
versely, SDF-1a did not induce the secretion of VEGF
in all cells examined.16-18 Similarly, VEGF stimulates
SDF-1a production, but SDF-1a may not alter VEGF
production in prostate cancer cell lines.16 These find-
ings suggest that SDF-1a may participate in VEGF-
and bFGF-regulated autocrine signaling systems that
are essential regulators of endothelial cell morpho-
genesis and angiogenesis. It was shown recently that
VEGF expression is increased in periodontal wounds
following the reparative process.29 Furthermore,
Wright et al.30 demonstrated that SDF-1a expression
is a target of TGF-b1 regulation. Under inflammatory
conditions, downregulation of SDF-1a production at
local sites of inflammation during the repair process
may promote wound healing by resolving the in-
flammatory phase and limiting the infiltration of
monocytes. Thus, the maintenance of normal tissue
architecture seems to be a pivotal role for SDF-1a,
and its loss or reduced expression may be altered in
inflammation.30
It is unknown why SDF-1a is produced at epithelial
surfaces. However, SDF-1a may play a key role in the
activation of the efferent immune system by regulat-
ing dendritic cell migration in addition to its role in reg-
ulating PMNs. Dendritic cells function as sentinels
of the immune system by trafficking from the vas-
culature to the tissues where, while immature, they
capture antigens.31 Then, following inflammatory
stimuli, they leave the tissues and move to the drain-
ing lymphoid organs where, converted into mature
dendritic cell, they prime naive T cells. A study31 dem-
onstrated that immature dendritic cells respond to
many inducible chemokines, including SDF-1a,
and, therefore, are likely to respond to agents that al-
ter SDF-1a levels. Epithelial cells lining the gastroin-
testinal mucosal surface, like those of the gingival
crevice, create a physical barrier between the external
luminal environment and are a key component of the
Figure 4.
SDF-1a levels in human GCF in healthy or diseased patients. A)
SDF-1a levels in diseased subjects were significantly higher compared
to healthy subjects. Subjects who received manual mechanical therapy
(scaling and root planing) demonstrated SDF-1a levels comparable to
healthy individuals ;6 weeks after treatment. SDF-1a levels in the
GCF of human subjects were stratified by PD. B) Sites with CAL
‡5 mm demonstrated 56% more SDF-1a (76.4 – 49.3 ng/mg)
than sites with PDs <5 mm (32.77 – 21.1 ng/mg). *Significance
at P <0.05.
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mucosal innate immune system. Mucosal integrity is
partially preserved by epithelial cell migration and
turnover. Smith et al.32 demonstrated the expression
of several chemokine receptors, notably CXCR4,
CCR5, CCR6, and CX3CR1, by the cells of the human
intestinal epithelium, suggesting that cells of the mu-
cosal barrier are likely targets for chemokine signals.
Akimoto et al.33 demonstrated that healing of human
gastric ulcers express high levels of VEGF receptors
early in ulcer development, and SDF-1a participates
in the initial stage of angiogenesis. SDF-1a receptors
are primarily expressed during the later stages of
wound healing, which suggests that SDF-1a may also
be involved in vascular maturation and gastric muco-
sal regeneration during late angiogenesis.33 Basal
levels of SDF-1a production and secretion into the
GCF may maintain the presence of immune surveil-
lance mechanisms in the gingival connective tissues.
CONCLUSIONS
This study demonstrated the expression of SDF-1a in
periodontal lesions and corresponding release in the
oral fluids (GCF) associated with diseased periodontal
sites. Furthermore, the induction of SDF-1a was
noted following the development of periodontitis in
a P. gingivalis LPS–mediated model of periodontal
disease progression. Thus, these data suggest that
SDF-1a may have a role in the development of peri-
odontal disease. Future studies may aid in the deter-
mination of the role SDF-1a serves as a biomarker of
the risk for periodontal disease progression.
ACKNOWLEDGMENTS
The authors appreciate the assistance of the Univer-
sity of Michigan Student Research Opportunity; Dr.
Rodrigo Neiva, Department of Periodontics and Oral
Medicine, University of Michigan School of Dentistry,
for his technical support; and support from the
Delta Dental Foundation of Okemos, Michigan. Dr.
Giannobile is supported by The National Institute
of Dental and Craniofacial Research (DE 16619),
Bethesda, Maryland. The authors report no conflicts
of interest related to this study.
REFERENCES
1. Kornman KS, Page RC, Tonetti MS. The host response
to the microbial challenge in periodontitis: Assembling
the players. Periodontol 2000 1997;14:33-53.
2. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-
based biomarkers of alveolar bone loss in periodonti-
tis. Ann N Y Acad Sci 2007;1098:230-251.
3. Nagasawa T, Nakajima T, Tachibana K, et al. Molec-
ular cloning and characterization of a murine pre-B-
cell growth-stimulating factor/stromal cell-derived
factor 1 receptor, a murine homolog of the human
immunodeficiency virus 1 entry coreceptor fusin. Proc
Natl Acad Sci USA 1996;93:14726-14729.
4. McGrath KE, Koniski AD, Maltby KM, McGann JK,
Palis J. Embryonic expression and function of the
chemokine SDF-1 and its receptor, CXCR4. Dev Biol
1999;213:442-456.
5. Imai K, Kobayashi M, Wang J, et al. Selective trans-
endothelial migration of hematopoietic progenitor cells:
A role in homing of progenitor cells. Blood 1999;93:
149-156.
6. Imai K, Kobayashi M, Wang J, et al. Selective secre-
tion of chemoattractants for haemopoietic progenitor
cells by bone marrow endothelial cells: A possible role
in homing of haemopoietic progenitor cells to bone
marrow. Br J Haematol 1999;106:905-911.
7. Gerard C, Rollins BJ. Chemokines and disease. Nat
Immunol 2001;2:108-115.
8. Rossi D, Zlotnik A. The biology of chemokines and their
receptors. Annu Rev Immunol 2000;18:217-242.
9. Rottman JB. Key role of chemokines and chemokine
receptors in inflammation, immunity, neoplasia, and
infectious disease. Vet Pathol 1999;36:357-367.
10. Park CH, Abramson ZR, Taba M Jr., et al. Three-
dimensional micro-computed tomographic imaging
of alveolar bone in experimental bone loss or repair.
J Periodontol 2007;78:273-281.
11. Kantarci A, Van Dyke TE. Neutrophil-mediated host
response to Porphyromonas gingivalis. J Int Acad
Periodontol 2002;4:119-125.
12. Darveau RP, Hancock RE. Procedure for isolation of
bacterial lipopolysaccharides from both smooth and
rough Pseudomonas aeruginosa and Salmonella
typhimurium strains. J Bacteriol 1983;155:831-838.
13. Page RC, Schroeder HE. Pathogenesis of inflammatory
periodontal disease. A summary of current work. Lab
Invest 1976;34:235-249.
14. Tiainen L, Asikainen S, Saxen L. Puberty-associated
gingivitis. Community Dent Oral Epidemiol 1992;20:
87-89.
15. Zadeh HH, Nichols FC, Miyasaki KT. The role of the
cell-mediated immune response to Actinobacillus act-
inomycetemcomitans and Porphyromonas gingivalis
in periodontitis. Periodontol 2000 1999;20:239-288.
16. Dai J, Kitagawa Y, Zhang J, et al. Vascular endothelial
growth factor contributes to the prostate cancer-
induced osteoblast differentiation mediated by bone
morphogenetic protein. Cancer Res 2004;64:994-
999.
17. Bautz F, Rafii S, Kanz L, Mohle R. Expression and
secretion of vascular endothelial growth factor-A by
cytokine-stimulated hematopoietic progenitor cells.
Possible role in the hematopoietic microenvironment.
Exp Hematol 2000;28:700-706.
18. Kijowski J, Baj-Krzyworzeka M, Majka M, et al. The
SDF-1-CXCR4 axis stimulates VEGF secretion and
activates integrins but does not affect proliferation and
survival in lymphohematopoietic cells. Stem Cells
2001;19:453-466.
19. Kim HK, Kim JE, Chung J, Han KS, Cho HI. Surface
expression of neutrophil CXCR4 is down-modulated
by bacterial endotoxin. Int J Hematol 2007;85:390-
396.
20. Lenoir M, Djerdjouri B, Perianin A. Stroma cell-derived
factor 1a mediates desensitization of human neu-
trophil respiratory burst in synovial fluid from rheu-
matoid arthritic patients. J Immunol 2004;172:7136-
7143.
SDF-1a Production in Periodontitis Volume 79 • Number 5
852
21. Link DC. Neutrophil homeostasis: A new role for stro-
mal cell-derived factor-1. Immunol Res 2005;32:169-
178.
22. Pelus LM, Bian H, Fukuda S, et al. The CXCR4 agonist
peptide, CTCE-0021, rapidly mobilizes polymorpho-
nuclear neutrophils and hematopoietic progenitor
cells into peripheral blood and synergizes with granu-
locyte colony-stimulating factor. Exp Hematol 2005;
33:295-307.
23. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF
induces stem cell mobilization by decreasing bone
marrow SDF-1 and up-regulating CXCR4. Nat Immu-
nol 2002;3:687-694.
24. Fedyk ER, Jones D, Critchley HO, et al. Expression of
stromal-derived factor-1 is decreased by IL-1 and TNF
and in dermal wound healing. J Immunol 2001;166:
5749-5754.
25. Hosokawa Y, Hosokawa I, Ozaki K, et al. CXCL12 and
CXCR4 expression by human gingival fibroblasts in
periodontal disease. Clin Exp Immunol 2005;141:
467-474.
26. Aust G, Steinert M, Kiessling S, Kamprad M, Simchen
C. Reduced expression of stromal-derived factor 1 in
autonomous thyroid adenomas and its regulation in
thyroid-derived cells. J Clin Endocrinol Metab 2001;
86:3368-3376.
27. Yun HJ, Jo DY. Production of stromal cell-derived
factor-1 (SDF-1) and expression of CXCR4 in human
bone marrow endothelial cells. J Korean Med Sci 2003;
18:679-685.
28. Salvucci O, Yao L, Villalba S, et al. Regulation of endo-
thelial cell branching morphogenesis by endogenous
chemokine stromal-derived factor-1. Blood 2002;99:
2703-2711.
29. Cooke JW, Sarment DP, Whitesman LA, et al. Effect of
rhPDGF-BB delivery on mediators of periodontal
wound repair. Tissue Eng 2006;12:1441-1450.
30. Wright N, de Lera TL, Garcia-Moruja C, et al. Trans-
forming growth factor-beta1 down-regulates expres-
sion of chemokine stromal cell-derived factor-1:
Functional consequences in cell migration and adhe-
sion. Blood 2003;102:1978-1984.
31. Caux C, Ait-Yahia S, Chemin K, et al. Dendritic cell biol-
ogy and regulation of dendritic cell trafficking by chemo-
kines. Springer Semin Immunopathol 2000;22:345-369.
32. Smith JM, Johanesen PA, Wendt MK, Binion DG,
Dwinell MB. CXCL12 activation of CXCR4 regulates
mucosal host defense through stimulation of epithelial
cell migration and promotion of intestinal barrier
integrity. Am J Physiol Gastrointest Liver Physiol 2005;
288:G316-G326.
33. Akimoto M, Hashimoto H, Maeda A, Shigemoto M,
Yamashita K. Roles of angiogenic factors and endo-
thelin-1 in gastric ulcer healing. Clin Sci 2002;103
(Suppl. 48):450S-454S.
Correspondence: Dr. Russell S. Taichman, Department of
Periodontics and Oral Medicine, University of Michigan
School of Dentistry, 1011 N. University Ave., Ann Arbor,
MI 48109-1078. E-mail: rtaich@umich.edu.
Submitted September 21, 2007; accepted for publication
November 26, 2007.
J Periodontol • May 2008 Havens, Chiu, Taba, et al.
853
